R Lor Randall

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. ncbi Complications of cemented long-stem hip arthroplasties in metastatic bone disease
    R Lor Randall
    Huntsman Cancer Institute, Department of Orthopaedics, Salt Lake City, UT 84112, USA
    Clin Orthop Relat Res 443:287-95. 2006
  2. pmc Complications of cemented long-stem hip arthroplasty in metastatic bone disease revisited
    Shawn L Price
    Department of Orthopaedics Sarcoma Services, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope Drive, Salt Lake City, UT, 84112, USA
    Clin Orthop Relat Res 471:3303-7. 2013
  3. pmc miRNA signatures associate with pathogenesis and progression of osteosarcoma
    Kevin B Jones
    Department of Orthopaedics and Center for Children s Cancer Research, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA
    Cancer Res 72:1865-77. 2012
  4. pmc Molecular inversion probe analysis detects novel copy number alterations in Ewing sarcoma
    Mona S Jahromi
    Center for Children s Cancer Research C3R, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA
    Cancer Genet 205:391-404. 2012
  5. pmc EWS/FLI-responsive GGAA microsatellites exhibit polymorphic differences between European and African populations
    Robert Beck
    Center for Children s Cancer Research, Huntsman Cancer Institute, University of Utah, Salt Lake City, USA
    Cancer Genet 205:304-12. 2012
  6. doi Reducing the risk of bone cement implantation syndrome during femoral arthroplasty
    David L Rothberg
    Department of Orthopaedics, University of Utah, Salt Lake City, UT 84108, USA
    Orthopedics 36:e463-7. 2013
  7. pmc At-risk populations for osteosarcoma: the syndromes and beyond
    George T Calvert
    Department of Orthopaedics and Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT 84112, USA
    Sarcoma 2012:152382. 2012
  8. pmc Extra-abdominal desmoid tumors associated with familial adenomatous polyposis
    George T Calvert
    Department of Orthopaedics and Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT 84112, USA
    Sarcoma 2012:726537. 2012
  9. pmc Salient features of mesenchymal stem cells-implications for Ewing sarcoma modeling
    Michael J Monument
    Sarcoma Services, Department of Orthopaedic Surgery, Huntsman Cancer Institute, University of Utah Salt Lake City, UT, USA
    Front Oncol 3:24. 2013
  10. pmc Potential for modulation of the fas apoptotic pathway by epidermal growth factor in sarcomas
    David E Joyner
    Department of Orthopaedics, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT 84112, USA
    Sarcoma 2011:847409. 2011

Collaborators

  • Kevin B Jones
  • Joshua D Schiffman
  • Stephen L Lessnick
  • George T Calvert
  • Richard Smith
  • Stefano Volinia
  • Rami I Aqeilan
  • Andreas Schuck
  • H J Siegel
  • T A Damron
  • Patrick C Toy
  • Kristy Weber
  • Valerae O Lewis
  • Albert J Aboulafia
  • Javad Parvizi
  • David E Joyner
  • Michael J Monument
  • Holly Zhou
  • Stephen K Aoki
  • David L Rothberg
  • Shawn L Price
  • Mona S Jahromi
  • Kenneth M Boucher
  • Robert Beck
  • Ryan B Israelsen
  • James S Meyer
  • J Sybil Biermann
  • Kenneth J Hunt
  • Mark Bernstein
  • Chris L Peters
  • Nicholas M Bernthal
  • Erik N Kubiak
  • M Aabid Farukhi
  • W Scott Watkins
  • Michelle Kinsey
  • Dafydd Thomas
  • Holly Spraker-Perlman
  • Jennifer Wright
  • Angelica R Putnam
  • Lynn B Jorde
  • David Lucas
  • Colleen Druzgal
  • Andrew Rosenberg
  • Benjamin E Illum
  • Susie Crabtree
  • J F Eary
  • Richard B Womer
  • Elizabeth R Lawlor
  • Richard Gorlick
  • Mark D Kailo
  • Kenneth L B Brown
  • Paula J Schomberg
  • Helen R Nadel
  • Holcombe E Grier
  • Neyssa Marina
  • John H Healey
  • Joshua Patt
  • Alan W Yasko
  • Michael K Wong
  • Ernest U Conrad
  • Joel Mayerson
  • Robert L Satcher
  • Sean V McGarry
  • Douglas Adkins
  • G Douglas Letson
  • Richard J O'Donnell
  • Brian Brigman
  • Robert Heck
  • Frank J Frassica
  • Deborah Frassica
  • Robert Benjamin
  • Victor Santana
  • Warren Chow
  • Suzanne George
  • Richard G Schmidt
  • Michael Paulussen
  • Lisa A Teot
  • Sohrab Gollogly
  • Herbert Juergens
  • Heinrich Kovar
  • Cheryl M Coffin
  • Teresa Maxwell
  • Robert E Goldsby
  • Arthur R Brothman

Detail Information

Publications23

  1. ncbi Complications of cemented long-stem hip arthroplasties in metastatic bone disease
    R Lor Randall
    Huntsman Cancer Institute, Department of Orthopaedics, Salt Lake City, UT 84112, USA
    Clin Orthop Relat Res 443:287-95. 2006
    ..Increased awareness of cement-related cardiopulmonary pathophysiology, and modifying conventional surgical techniques can minimize cement-associated complications...
  2. pmc Complications of cemented long-stem hip arthroplasty in metastatic bone disease revisited
    Shawn L Price
    Department of Orthopaedics Sarcoma Services, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope Drive, Salt Lake City, UT, 84112, USA
    Clin Orthop Relat Res 471:3303-7. 2013
    ..Embolic events may precipitate cardiopulmonary complications and even death; by contrast, others have reported that the use of a cemented long-stem femoral arthroplasty in patients with metastatic bone disease is a safe procedure...
  3. pmc miRNA signatures associate with pathogenesis and progression of osteosarcoma
    Kevin B Jones
    Department of Orthopaedics and Center for Children s Cancer Research, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA
    Cancer Res 72:1865-77. 2012
    ..Thus, our findings establish a miRNA signature associated with pathogenesis of osteosarcoma as well as critical pre-treatment biomarkers of metastasis and responsiveness to therapy...
  4. pmc Molecular inversion probe analysis detects novel copy number alterations in Ewing sarcoma
    Mona S Jahromi
    Center for Children s Cancer Research C3R, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA
    Cancer Genet 205:391-404. 2012
    ..CNAs detected by microarray correlate with outcome and may be useful for risk stratification in future clinical trials...
  5. pmc EWS/FLI-responsive GGAA microsatellites exhibit polymorphic differences between European and African populations
    Robert Beck
    Center for Children s Cancer Research, Huntsman Cancer Institute, University of Utah, Salt Lake City, USA
    Cancer Genet 205:304-12. 2012
    ..These data suggest that GGAA microsatellite polymorphisms in the NR0B1 gene might influence disease susceptibility and prognosis in Ewing sarcoma in unanticipated ways...
  6. doi Reducing the risk of bone cement implantation syndrome during femoral arthroplasty
    David L Rothberg
    Department of Orthopaedics, University of Utah, Salt Lake City, UT 84108, USA
    Orthopedics 36:e463-7. 2013
    ..The proposed mechanism of risk reduction is through lower intramedullary pressure with no bone-cement-implant interface pullout strength reduction. Further clinical trials are needed to prove this biomechanical effect...
  7. pmc At-risk populations for osteosarcoma: the syndromes and beyond
    George T Calvert
    Department of Orthopaedics and Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT 84112, USA
    Sarcoma 2012:152382. 2012
    ..This paper reviews the genetic and clinical features of the known osteosarcoma predisposition syndromes...
  8. pmc Extra-abdominal desmoid tumors associated with familial adenomatous polyposis
    George T Calvert
    Department of Orthopaedics and Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT 84112, USA
    Sarcoma 2012:726537. 2012
    ..This paper analyzes recent evidence pertaining to the epidemiology, molecular biology, histopathology, screening, and treatment of extra-abdominal desmoid tumors associated with familial adenomatous polyposis syndrome...
  9. pmc Salient features of mesenchymal stem cells-implications for Ewing sarcoma modeling
    Michael J Monument
    Sarcoma Services, Department of Orthopaedic Surgery, Huntsman Cancer Institute, University of Utah Salt Lake City, UT, USA
    Front Oncol 3:24. 2013
    ....
  10. pmc Potential for modulation of the fas apoptotic pathway by epidermal growth factor in sarcomas
    David E Joyner
    Department of Orthopaedics, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT 84112, USA
    Sarcoma 2011:847409. 2011
    ..Cells destined for elimination inhibit this prosurvival response via a presently undefined pathway. This scenario represents a novel role for EGF and CTGF as regulators of the Fas pathway in sarcomas...
  11. pmc Extremity sarcoma surgery in younger children: ten years of patients ten years and under
    Ryan B Israelsen
    Department of Orthopaedic Surgery, University of Utah, Salt Lake City, USA
    Iowa Orthop J 31:145-53. 2011
    ..Sarcoma surgery in the younger growing child presents challenges for the surgeon, patient, and parents, but is usually successful in the long-term...
  12. ncbi Grade 1 chondrosarcoma of bone: a diagnostic and treatment dilemma
    R Lor Randall
    Department of Orthopedics, Huntsman Cancer Institute and Primary Children s Medical Center, University of Utah, Salt Lake City, UT 84112 5550, USA
    J Natl Compr Canc Netw 3:149-56. 2005
    ..We discuss the promise of emerging molecular technologies. Finally, we provide a review of the available literature on treatment outcomes, along with a discussion of our own particular preferences...
  13. pmc Fas death pathway in sarcomas correlates with epidermal growth factor transcription
    David E Joyner
    Department of Orthopaedics, Sarcoma Services, Huntsman Cancer Institute, University of Utah School of Medicine, 2000 Circle of Hope, Salt Lake City, UT 84112, USA
    Clin Orthop Relat Res 466:2092-8. 2008
    ..The results suggest ligand activity in the Fas death pathway correlates with EGF transcription in sarcomas...
  14. ncbi Sacral resection and reconstruction for tumors and tumor-like conditions
    R Lor Randall
    Sarcoma Services, Department of Orthopedics, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA
    Orthopedics 28:307-13. 2005
    ..The complication rate was 33%. Tumor control was achieved in 73%. Postoperative complications occurred in 33%. Sacral resection remains a challenging operation...
  15. ncbi Her-2/neu expression in osteosarcoma increases risk of lung metastasis and can be associated with gene amplification
    Holly Zhou
    Department of Pathology, University of Utah, Salt Lake City, UT, USA
    J Pediatr Hematol Oncol 25:27-32. 2003
    ..Whether Her-2/neu expression influences outcome needs to be examined further in a prospective fashion. The hope is that Her-2/neu expression will identify patients who may benefit from the addition of directed biologic therapy...
  16. ncbi Surgical fixation of pathologic fractures: an evaluation of evolving treatment methods
    Kenneth J Hunt
    Sarcoma Service, Department of Orthopedics, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Suite 2100, Salt Lake City, Utah 84112, USA
    Bull Hosp Jt Dis 63:77-82. 2006
    ..02). This data, in addition to several additional advantages of indirect reduction and intramedullary fixation of pathologic fractures, supports this method of fracture care over open reduction and internal fixation in appropriate cases...
  17. ncbi Management of lower-extremity bone metastasis
    Kristy L Weber
    Department of Orthopaedic Surgery, Johns Hopkins School of Medicine, 601 North Caroline Street, Baltimore, MD 21287, USA
    J Bone Joint Surg Am 88:11-9. 2006
  18. ncbi Bone cancer
    J Sybil Biermann
    University of Michigan Comprehensive Cancer Center, USA
    J Natl Compr Canc Netw 5:420-37. 2007
  19. ncbi Reconstruction of noncontained distal femoral defects with polymethylmethacrylate and crossed-screw augmentation: a biomechanical study
    Patrick C Toy
    Department of Orthopaedic Surgery, University of Tennessee Campbell Clinic, 1211 Union Avenue, Suite 510, Memphis, TN 38104, USA
    J Bone Joint Surg Am 88:171-8. 2006
    ..This biomechanical study was undertaken to determine whether augmenting the cement with crossed screws would result in a stronger reconstruction...
  20. ncbi Transit tumor retrieval preserves RNA fidelity and obviates snap-freezing
    R Lor Randall
    Hunstman Cancer Institute SARC Lab and Primary Children s Medical Center, Syracuse, NY, USA
    Clin Orthop Relat Res 438:149-57. 2005
    ....
  21. ncbi Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor Committee
    James S Meyer
    Department of Radiology, Children s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Pediatr Blood Cancer 51:163-70. 2008
    ..Recommended examinations may become required in the future. These guidelines should be considered a work in progress that will evolve with advances in imaging and childhood cancer research...
  22. ncbi An approach to the management of the patient with metastatic bone disease
    Kristy L Weber
    Section of Orthopaedic Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA
    Instr Course Lect 53:663-76. 2004
    ..Treatment includes stabilization with the latest prosthetic implants and new devices. Advances in the field of radiation oncology and bisphosphonate use in patients with bone metastasis are other management approaches...
  23. ncbi Ewing's sarcoma family of tumors: current management
    Mark Bernstein
    Service of Hematology Oncology, Ste Justine Hospital, University of Montreal, 3175 Cote Ste Catherine Road, Montreal, Quebec, H3T 1C5, Canada
    Oncologist 11:503-19. 2006
    ..New approaches include anti-angiogenic therapy, particularly since vascular endothelial growth factor is an apparent downstream target of the ews-fli1 oncogene...